As of March 2, we're $15,300 in the red for the quarter. Donate here to support this vital work
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Is Big Pharma Addicted To Fraud?
Key Excerpts from Article on Website of Forbes


Forbes, July 29, 2013
Posted: October 29th, 2013
http://www.forbes.com/sites/erikakelton/2013/07/29/is-big-ph...

Recent news out of China raises the question once again of whether any aspect of the pharmaceutical business can be trusted. First, Chinese authorities announced they were investigating GlaxoSmithKline and other pharma companies for bribing doctors, hospitals and government officials to buy and prescribe their drugs. Glaxo is accused of using a Shanghai travel agency to funnel at least $489 million in bribes. Then the New York Times revealed last week the alarming news that an internal Glaxo audit found serious problems with the way research was conducted at the companys Shanghai research and development center. Last year Glaxo paid $3 billion to resolve civil and criminal allegations of, among other things, marketing widely used prescription drugs for unapproved treatments and using kickbacks to promote sales. Glaxo is a leader in pharma fraud and wrongdoing, with other industry heavyweights close behind. Over the past decade, whistleblowers and government investigations in the US have exposed a never-ending series of problems by numerous pharma companies in all facets of the industry, starting with fraudulent research papers used to bolster marketing and continuing through to the manufacture of contaminated and defective products, the marketing of drugs for unapproved and life-threatening uses and the mispricing of prescription drugs. Pharma ... has paid more than $30.2 billion in civil and criminal penalties to the US and state governments and continues to face more allegations of wrongdoing. The industry despite huge penalties and a long string of public mea culpas has a fraud habit that is just too profitable to kick. Finding a cure should be a top priority of regulators worldwide.

Note: For more on pharmaceutical industry corruption, see the deeply revealing reports from reliable major media sources available here.


Latest News


Key News Articles from Years Past